← All organizations
Highest phase reached
Phase 4
First clinical trial
Aug 1, 2006Last known activity
May 2, 2023
Timeline
2000s
- Jun 1, 2001
NHS Lothian— Founded
Drugs by trial phase (81 distinct, 57 trials)
Phase 4 (20 own, 0 via acquisition)
Phase 3 (18 own, 0 via acquisition)
Phase 2 (16 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Indications
Studied for
- Acute Kidney Injury
- Amyotrophic Lateral Sclerosis
- Aneurysm
- Aortic Aneurysm, Abdominal
- Aortic Valve Stenosis
- Arthritis
- Arthritis, Rheumatoid
- Atrial Fibrillation
- Atrial Flutter
- Bile Duct Neoplasms
- Blood Coagulation Disorders
- Bronchiectasis
- Calcinosis
- Carcinoma, Non-Small-Cell Lung
- Cerebral Small Vessel Diseases
- Cerebrovascular Disorders
- Colitis
- Colitis, Ulcerative
- Constriction, Pathologic
- Cysts
- Depression
- Depressive Disorder
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Drug Overdose
- Emergencies
- Fatty Liver
- Fibrosis
- Ganglion Cysts
- Gastrointestinal Neoplasms
- Hematoma
- Hematoma, Subdural
- Hemorrhage
- Hemostatic Disorders
- Hypertension
- Hypertension, Portal
- Inflammation
- Intracranial Hemorrhage, Hypertensive
- Intracranial Hemorrhages
- Ischemia
- Kidney Diseases
- Leiomyoma
- Liver Cirrhosis
- Liver Diseases
- Lung Neoplasms
- Menorrhagia
- Motor Neuron Disease
- Myelitis
- Myelitis, Transverse
- Myofibroma
- Neoplasms, Unknown Primary
- Neuromyelitis Optica
- Non-alcoholic Fatty Liver Disease
- Osteogenesis Imperfecta
- Parkinson Disease
- Peripheral Nervous System Diseases
- Placenta, Retained
- Poisoning
- Pseudomonas Infections
- Reperfusion Injury
- Schizophrenia
- Schizophrenia Spectrum and Other Psychotic Disorders
- Subarachnoid Hemorrhage
- Ulcer
- Wounds and Injuries
Recent trials (50)
- NCT06487975OfficialN/AMay 2, 2023
- NCT04731103CollaboratorPhase 2Jun 30, 2021
- NCT04648033CollaboratorPhase 1Nov 30, 2020
- NCT04591639CollaboratorN/AAug 19, 2020
- NCT04276740Overall official - principal investigatorPhase 2Apr 1, 2020
- NCT04302870CollaboratorPhase 2/Phase 3Feb 27, 2020
- NCT03737617CollaboratorPhase 4Dec 5, 2019
- NCT04276727CollaboratorPhase 2Nov 4, 2019
- NCT03652870CollaboratorPhase 3Nov 1, 2019
- NCT03659864CollaboratorN/ASep 3, 2018
- NCT03463694Overall official - principal investigatorN/AAug 31, 2018
- NCT03407573Lead sponsorN/AOct 1, 2017
- NCT03153150CollaboratorPhase 3Jul 3, 2017
- NCT03177395CollaboratorPhase 1Jun 8, 2017
- NCT02669875CollaboratorPhase 2May 31, 2017
Details
- Founded
- Edinburgh, GB Jun 1, 2001
- Last known activity
- May 2, 2023